Nadir CA125 concentration as a prognostic indicator in ovarian cancer

被引：2
|
作者：
Baron, AT
Maihle, N
机构：
[1] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06511 USA
[2] Univ Kentucky, Lucille P Markey Canc Ctr, Coll Publ Hlth, Lexington, KY USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 06期
关键词：
CA125; chemotherapy; epithelial ovarian carcinoma; prognosis; tumor marker;
D O I：
10.1038/ncponc0178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [41] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - COMPARISON WITH CA125 AS A PREOPERATIVE PROGNOSTIC INDICATOR IN ADVANCED OVARIAN-CANCER
    VENESMAA, P
    LEHTOVIRTA, P
    STENMAN, UH
    LEMINEN, A
    FORSS, M
    YLIKORKALA, O
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1188 - 1190
  • [42] Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer
    Erdemoglu, E
    Kamaci, M
    Özen, S
    Sahin, HG
    Kolusari, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (02) : 195 - 196
  • [43] Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study
    He, Can
    Thapa, Niresh
    Wang, Yang
    Song, Ziye
    Yang, Jing
    Xu, Mengfei
    Zuo, Na
    Cai, Hongbing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2223 - 2230
  • [44] Prognostic value of serial CA125 measurements during chemotherapy for patients with advanced ovarian cancer
    Koper, NP
    Massuger, LFAG
    Thomas, CMG
    Kiemeney, LALM
    Schijf, CPT
    Beex, LVAM
    Verbeek, ALM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (02) : 127 - 133
  • [45] HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER
    BICHEL, P
    JAKOBSEN, A
    ORNTOFT, TF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (05) : 199 - 204
  • [46] Correlates of the preoperative level of CA125 at presentation of ovarian cancer
    Cramer, Daniel W.
    Vitonis, Allison F.
    Welch, William R.
    Terry, Kathryn L.
    Goodman, Annekathryn
    Rueda, Bo R.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 462 - 468
  • [47] CA125 response to bevacizumab in recurrent ovarian cancer.
    O'Cearbhaill, R. E.
    Zhou, Q.
    Iasonos, A.
    Diaz, J. P.
    Tew, W. P.
    Hensley, M. L.
    O'Flaherty, C.
    Aghajanian, C.
    Spriggs, D. R.
    Sabbatini, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Combined inhibin and CA125 assays in the detection of ovarian cancer
    Robertson, DM
    Cahir, N
    Burger, HG
    Mamers, P
    McCloud, PI
    Pettersson, K
    McGuckin, M
    CLINICAL CHEMISTRY, 1999, 45 (05) : 651 - 658
  • [49] Beyond CA125: the coming of age of ovarian cancer biomarkers
    Sasaroli, Dimitra
    Coukos, George
    Scholler, Nathalie
    BIOMARKERS IN MEDICINE, 2009, 3 (03) : 275 - 288
  • [50] Serum CA125 level before the development of ovarian cancer
    Kobayashi, H.
    Ooi, H.
    Yamada, Y.
    Sakata, M.
    Kawaguchi, R.
    Kanayama, S.
    Sumimoto, K.
    Terao, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 99 (02) : 95 - 99
12345